Cedrus »

Akebia Therapeutics shares owned by Cedrus

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Cedrus from 13F filings

Historical chart of Cedrus investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Cedrus consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Cedrus

Quarter filed Position value Share count Share price at filing
2024-06-30 $14k 14k 1.02

More positions owned by Cedrus

Vanguard Index Fds Growth Etf (VUG)
First Tr Exchng Traded Fd Vi Tcw Opportunis (FIXD)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
First Tr Exchange-traded Cap Strength Etf (FTCS)
First Tr Exchange-traded Ft Vest Ris (RDVI)
First Tr Exchng Traded Fd Vi Low Dur Strtgc (LDSF)
Wisdomtree Tr Glb Us Qtly Div (DNL)
Vanguard World Mega Cap Val Etf (MGV)
Ishares Tr MRGSTR MD CP GRW (IMCG)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr 10-20 Yr Trs Etf (TLH)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Apple (AAPL)

View all positions for Cedrus

Top funds holding Akebia Therapeutics

BlackRock
Vanguard Group
Geode Capital Management
Acadian Asset Management
Renaissance Technologies
State Street Corporation
Jacobs Levy Equity Management
Qube Research & Technologies
Connor, Clark & Lunn Investment Management
Federated Investors
Susquehanna International
Morgan Stanley
Bank of New York Mellon
Charles Schwab Investment Management
Citadel Advisors

View all funds holding Akebia Therapeutics